Dr. Berkovich is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Regina Berkovich MD, PhD Inc
8727 Beverly Blvd, Ste B
West Hollywood, CA 90048Phone+1 310-474-9595Fax+1 866-737-9505- Is this information wrong?
Summary
- Dr. Regina Berkovich is an MS and NMOSD expert neurologist in West Hollywood, CA; affiliated with USC (Teaching Faculty) and LAC+USC (Attending Neurologist). MD: Kazan State Medical University, 1991; PhD: Clinical Pharmacology 1996. Expertise: MS, NMOSD, other CNS inflammatory conditions and neurosarcioidosis; MS and NMO Relapses; Symptomatic therapy (Botox); PI of many clinical trials, incl. IITs
Education & Training
- Kazan State Medical UniversityClass of 1991
- University Kazan State Medical UniversityBachelor's, 1991
Certifications & Licensure
- CA State Medical License 2008 - 2026
Awards, Honors, & Recognition
- Top Doctors Certificate Pasadena Magazine, 2010
- Special Award for Organization of the 5th European Conference of Neuro-Psycho-Pharmacology 2000
- Gold Medal and Gold Certificate of Ministry of Education 1985
Clinical Trials
- Pulse ACTH vs. MP for MS Start of enrollment: 2009 Nov 01
- A Pilot Study to Characterize the Biological Effect of a Pre-planned 12 Week Dose Interruption of Natalizumab Start of enrollment: 2019 Jul 03
- A Study of Suboptimally Controlled Participants Previously Taking Oral or Infusion DMDs for RMS (MASTER-2) Start of enrollment: 2019 Jul 22
Roles: Principal Investigator
Publications & Presentations
PubMed
- Menthol dural application alters meningeal arteries tone and enhances excitability of trigeminocervical neurons in rats.Sokolov, A., Mengal, M., Berkovich, R.> ;Brain Research. 2024 Feb 15
- 1 citationsMeta-analysis of the effects of anti-migraine therapeutics in the rat trigeminovascular nociception model as a tool for design optimization.Antonina Dolgorukova, Ekaterina Protsenko, Julia Isaeva, Victoria Gagloeva, Elena Verbitskaya, Regina Berkovich, Alexey Y Sokolov> ;The European Journal of Neuroscience. 2023 Jul 1
- Comparative pharmacokinetics and bioavailability of monomethyl fumarate following a single oral dose of Bafiertam® (monomethyl fumarate) versus Vumerity® (diroximel fu...Franck S Rousseau, Laurene Wang, Tiffany N Sprague, Thomas W Lategan, Regina R Berkovich> ;Multiple Sclerosis and Related Disorders. 2023 Feb 1
- Join now to see all
Journal Articles
- Intravenous Dextromethorphan/Quinidine Inhibits Activity of Dura-sensitive Spinal Trigeminal Neurons in RatsBerkovich R., Sokolov A., Lyubashina O, European Journal of Pain, 1/1/2014
- Intravenous Valproate Inhibits Ongoing and Evoked Activity of Dura-sensitive Thalamic Neurons in RatsSokolov AY, Lyubashina OA, Sivachenko IB, Berkovich RR, Panteleev SS, Eur J Pharmacol, 1/31/2013
- Therapeutic Mechanisms of Action of Adrenocorticotropic Hormone (ACTH) And Other Melanocortin Peptides for the Clinical Management of Patients with MSArnason B, Berkovich R, Catania A. et al., Mult Scler, 1/1/2013
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Pilot Study of Monthly Pulse Adrenocorticotropic Hormone (ACTH) Or Methylprednisolone as an Add-on Therapy to Beta-interferons for Long-term Treatment of Multiple Scle...Berkovich R, Amezcua L, Subhani D, Cen S, American Academy of Neurology's 65th Annual Meeting, San Diego, CA, 1/16/2013
- Pilot Study of Monthly Pulse Adrenocorticotropic Hormone or Methylprednisolone as an Add-on Therapy to Beta-interferons for Long-term Treatment of Multiple SclerosisAmezcua L, Axtell R, Cen S, Tauhid S; Neema M, Subhani D, Bakshi R, Steinman L and Berkovich R, 29th European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Copenhagen, Denmark, 1/2/2013
- Dynamics of the Peripheral Blood CD4 Cell Counts of JCV Ab Positive Patients at the Different Phases of Natalizumab TreatmentBerkovich R, Togasaki D, Subhani D, Steinman L, ECTRIMS, Lyon, France, 1/12/2012
- Join now to see all
Lectures
- Clinical Experience with Aubagio [Launching of Aubagio in Russian Federation]Yaroslavl, Russia - 1/24/2014
- Immunomodulatory Treatment Options for Multiple SclerosisOregon - 1/17/2014
- Clinical Experience with Aubagio. [Launching of Aubagio in European Union]Brussels, Belgium - 1/12/2014
- Join now to see all
Other
- Multiple Sclerosis: Treatment of Its SymptomsBerkovich R, Kantor D, Reder AT, MedLink Neurology, MedLink Corporation
http://www.medlink.com
San Diego - 1/4/2013 - Immunomodulatory Agents in MS: Clinical Trials and TherapyBerkovich R, Kantor D, Reder AT, MedLink Neurology, MedLink Corporation
http://www.medlink.com
San Diego - 1/10/2002
Press Mentions
- Regina R. Berkovich, MD, PhD, a Neurologist with Medical Imaging Center of Southern CaliforniaDecember 12th, 2019
- A New Treatment Option for People with Multiple Sclerosis on Coast LiveJuly 24th, 2019
- IV Hydrogen Peroxide: An Unproven Therapy That Could Be DangerousSeptember 5th, 2017
- Join now to see all
Other Languages
- Polish
Hospital Affiliations
- Keck Hospital of USCLos Angeles, California
- Los Angeles General Medical CenterLos Angeles, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: